Treatment preferences and involvement in treatment decision making of patients with endometrial cancer and clinicians

Por Kunneman, M, Pieterse, A H, Stiggelbout, A M, Nout, R A, Kamps, M, Lutgens, L C H W, Paulissen, J, Mattheussens, O J A, Kruitwagen, R F P M, Creutzberg, C L
Publicado em 2014

Consecutive magnetic resonance imaging during brachytherapy for cervical carcinoma: predictive value of volume measurements with respect to persistent disease and prognosis

Por Mongula, J. E., Slangen, B. F. M., Lambregts, D. M. J., Cellini, F., Bakers, F. C. H., Lutgens, L. C. H. W., Van Gorp, T., Kruse, A.J., Kruitwagen, R. F. P. M., Beets-Tan, R. G. H.
Publicado no Radiat Oncol (2015)

Ten-year results of the PORTEC-2 trial for high-intermediate risk endometrial carcinoma: improving patient selection for adjuvant therapy

Por Wortman, B. G., Creutzberg, C. L., Putter, H., Jürgenliemk-Schulz, I. M., Jobsen, J. J., Lutgens, L. C. H. W., van der Steen-Banasik, E. M., Mens, J. W. M., Slot, A., Kroese, M. C. Stenfert, van Triest, B., Nijman, H. W., Stelloo, E., Bosse, T., de Boer, S. M., van Putten, W. L. J., Smit, V. T. H. B. M, Nout, R. A.
Publicado no Br J Cancer (2018)